The clinical implication of serotype distribution and drug resistance of invasive pneumococcal disease in children: A single center study in southern Taiwan during 2010-2016.
CONCLUSION: The increase in the prevalence of CNSP using meningitis breakpoint was observed since 2013. For treating pneumococcal meningitis, empirical therapy with vancomycin and ceftriaxone is warranted. Although the non-PCV13-specific serotypes reported in our study caused no morbidity and mortality, further monitoring and surveillance are still recommended.
PMID: 31103534 [PubMed - as supplied by publisher]
Source: Journal of Microbiology, Immunology, and Infection - Category: Microbiology Authors: Lee MC, Kuo KC Tags: J Microbiol Immunol Infect Source Type: research
More News: Allergy & Immunology | Ceftriaxone | Children | Epidemiology | Men | Meningitis | Meningitis Vaccine | Microbiology | Pediatrics | Pneomococcal Vaccine | Rocephin | Statistics | Study | Taiwan Health | Vaccines